Shopping Cart 0
Cart Subtotal
USD 0

Global Next Generation Diabetes Therapy and Drug Delivery Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 3480

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5220

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 6960
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level.

Scope of the Report:

This report studies the Next Generation Diabetes Therapy and Drug Delivery market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Next Generation Diabetes Therapy and Drug Delivery market by product type and applications/end industries.

The market growth is attributed to the rise in the number of diabetic patients globally and the increase in disposable income among these patients. The benefits of using these advanced devices over conventional products, such as painless mode of insulin delivery and improvement in adherence to medication, and rise in the healthcare expenditure are expected to increase the demand for these products, thus fueling the market growth. However, lack of awareness, cost restrains in the developing regions, and less variability in products are expected to hamper the growth.

Asia-Pacific possesses high market potential for the growth of next generation diabetes therapy and drug delivery market, owing to increase in demand for advanced diabetic products, high incidence of diabetes, and rise in healthcare expenditure. It has experienced fast-paced growth, in terms of production and development of advanced diabetic products.

The global Next Generation Diabetes Therapy and Drug Delivery market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Next Generation Diabetes Therapy and Drug Delivery.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Johnson & Johnson

Abbott Laboratories

Medtronic

Sanofi

Novo Nordisk

MannKind Corporation

Enteris BioPharma

Dexcom

Senseonics

Medtech

Synertech

Zosano Pharma

Relmada Therapeutics

Eli Lilly and Company

Transdermal Specialties

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Inhalable Insulin

Oral Insulin

Insulin Patches

CGM Systems

Artificial Pancreas

Market Segment by Applications, can be divided into

Diagnostic/Clinics

ICUs

Home Healthcare

READ MORE

Table Of Content

Scope

Table of Contents

1 Next Generation Diabetes Therapy and Drug Delivery Market Overview

1.1 Product Overview and Scope of Next Generation Diabetes Therapy and Drug Delivery

1.2 Classification of Next Generation Diabetes Therapy and Drug Delivery by Types

1.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Comparison by Types (2017-2023)

1.2.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Types in 2017

1.2.3 Inhalable Insulin

1.2.4 Oral Insulin

1.2.5 Insulin Patches

1.2.6 CGM Systems

1.2.7 Artificial Pancreas

1.3 Global Next Generation Diabetes Therapy and Drug Delivery Market by Application

1.3.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Diagnostic/Clinics

1.3.3 ICUs

1.3.4 Home Healthcare

1.4 Global Next Generation Diabetes Therapy and Drug Delivery Market by Regions

1.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Next Generation Diabetes Therapy and Drug Delivery Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Next Generation Diabetes Therapy and Drug Delivery Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Next Generation Diabetes Therapy and Drug Delivery Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Next Generation Diabetes Therapy and Drug Delivery Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Next Generation Diabetes Therapy and Drug Delivery Status and Prospect (2013-2023)

1.5 Global Market Size of Next Generation Diabetes Therapy and Drug Delivery (2013-2023)

2 Manufacturers Profiles

2.1 Johnson & Johnson

2.1.1 Business Overview

2.1.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.2 Abbott Laboratories

2.2.1 Business Overview

2.2.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.3 Medtronic

2.3.1 Business Overview

2.3.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.4 Sanofi

2.4.1 Business Overview

2.4.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.5 Novo Nordisk

2.5.1 Business Overview

2.5.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.6 MannKind Corporation

2.6.1 Business Overview

2.6.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.7 Enteris BioPharma

2.7.1 Business Overview

2.7.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.8 Dexcom

2.8.1 Business Overview

2.8.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.9 Senseonics

2.9.1 Business Overview

2.9.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.10 Medtech

2.10.1 Business Overview

2.10.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.11 Synertech

2.11.1 Business Overview

2.11.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.12 Zosano Pharma

2.12.1 Business Overview

2.12.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.13 Relmada Therapeutics

2.13.1 Business Overview

2.13.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.14 Eli Lilly and Company

2.14.1 Business Overview

2.14.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.15 Transdermal Specialties

2.15.1 Business Overview

2.15.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

3 Global Next Generation Diabetes Therapy and Drug Delivery Market Competition, by Players

3.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Next Generation Diabetes Therapy and Drug Delivery Players Market Share

3.2.2 Top 10 Next Generation Diabetes Therapy and Drug Delivery Players Market Share

3.3 Market Competition Trend

4 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Regions

4.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue and Market Share by Regions

4.2 North America Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

4.3 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

4.5 South America Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

5 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries

5.1 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)

5.2 USA Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

5.3 Canada Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

5.4 Mexico Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

6 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries

6.1 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)

6.2 Germany Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

6.3 UK Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

6.4 France Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

6.5 Russia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

6.6 Italy Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries

7.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)

7.2 China Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

7.3 Japan Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

7.4 Korea Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

7.5 India Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

8 South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries

8.1 South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)

8.2 Brazil Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

8.3 Argentina Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

8.4 Colombia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Next Generation Diabetes Therapy and Drug Delivery by Countries

9.1 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)

9.2 Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

9.3 UAE Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

9.4 Egypt Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

9.5 Nigeria Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

9.6 South Africa Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

10 Global Next Generation Diabetes Therapy and Drug Delivery Market Segment by Type

10.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue and Market Share by Type (2013-2018)

10.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Type (2018-2023)

10.3 Inhalable Insulin Revenue Growth Rate (2013-2023)

10.4 Oral Insulin Revenue Growth Rate (2013-2023)

10.5 Insulin Patches Revenue Growth Rate (2013-2023)

10.6 CGM Systems Revenue Growth Rate (2013-2023)

10.7 Artificial Pancreas Revenue Growth Rate (2013-2023)

11 Global Next Generation Diabetes Therapy and Drug Delivery Market Segment by Application

11.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2013-2018)

11.2 Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Application (2018-2023)

11.3 Diagnostic/Clinics Revenue Growth (2013-2018)

11.4 ICUs Revenue Growth (2013-2018)

11.5 Home Healthcare Revenue Growth (2013-2018)

12 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast (2018-2023)

12.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast (2018-2023)

12.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Regions (2018-2023)

12.3 North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

12.4 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

12.6 South America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Next Generation Diabetes Therapy and Drug Delivery Picture

Table Product Specifications of Next Generation Diabetes Therapy and Drug Delivery

Table Global Next Generation Diabetes Therapy and Drug Delivery and Revenue (Million USD) Market Split by Product Type

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Types in 2017

Figure Inhalable Insulin Picture

Figure Oral Insulin Picture

Figure Insulin Patches Picture

Figure CGM Systems Picture

Figure Artificial Pancreas Picture

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) by Application (2013-2023)

Figure Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Applications in 2017

Figure Diagnostic/Clinics Picture

Figure ICUs Picture

Figure Home Healthcare Picture

Table Global Market Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2013-2023)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors

Table Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Medtronic Basic Information, Manufacturing Base and Competitors

Table Medtronic Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Novo Nordisk Basic Information, Manufacturing Base and Competitors

Table Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table MannKind Corporation Basic Information, Manufacturing Base and Competitors

Table MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Enteris BioPharma Basic Information, Manufacturing Base and Competitors

Table Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Dexcom Basic Information, Manufacturing Base and Competitors

Table Dexcom Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Senseonics Basic Information, Manufacturing Base and Competitors

Table Senseonics Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Medtech Basic Information, Manufacturing Base and Competitors

Table Medtech Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Synertech Basic Information, Manufacturing Base and Competitors

Table Synertech Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Zosano Pharma Basic Information, Manufacturing Base and Competitors

Table Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Relmada Therapeutics Basic Information, Manufacturing Base and Competitors

Table Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors

Table Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Transdermal Specialties Basic Information, Manufacturing Base and Competitors

Table Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) by Players (2013-2018)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Players (2013-2018)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Players in 2016

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Players in 2017

Figure Global Top 5 Players Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share in 2017

Figure Global Top 10 Players Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share in 2017

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) by Regions (2013-2018)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Regions (2013-2018)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Regions (2013-2018)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Regions in 2017

Figure North America Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Europe Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure South America Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Table North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)

Table North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries (2013-2018)

Figure North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries (2013-2018)

Figure North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries in 2017

Figure USA Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Canada Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Mexico Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Table Europe Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) by Countries (2013-2018)

Figure Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries (2013-2018)

Figure Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries in 2017

Figure Germany Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure UK Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure France Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Russia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Italy Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries in 2017

Figure China Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Japan Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Korea Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure India Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Table South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)

Table South America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries (2013-2018)

Figure South America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries (2013-2018)

Figure South America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries in 2017

Figure Brazil Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Argentina Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Colombia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries in 2017

Figure Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure UAE Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Egypt Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Nigeria Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure South Africa Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) by Type (2013-2018)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Type (2013-2018)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Type (2013-2018)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Type in 2017

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue Forecast by Type (2018-2023)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Share Forecast by Type (2018-2023)

Figure Global Inhalable Insulin Revenue Growth Rate (2013-2018)

Figure Global Oral Insulin Revenue Growth Rate (2013-2018)

Figure Global Insulin Patches Revenue Growth Rate (2013-2018)

Figure Global CGM Systems Revenue Growth Rate (2013-2018)

Figure Global Artificial Pancreas Revenue Growth Rate (2013-2018)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2013-2018)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Application (2013-2018)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Application (2013-2018)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Application in 2017

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue Forecast by Application (2018-2023)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Share Forecast by Application (2018-2023)

Figure Global Diagnostic/Clinics Revenue Growth Rate (2013-2018)

Figure Global ICUs Revenue Growth Rate (2013-2018)

Figure Global Home Healthcare Revenue Growth Rate (2013-2018)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

Figure Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

Figure South America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Johnson & Johnson

Abbott Laboratories

Medtronic

Sanofi

Novo Nordisk

MannKind Corporation

Enteris BioPharma

Dexcom

Senseonics

Medtech

Synertech

Zosano Pharma

Relmada Therapeutics

Eli Lilly and Company

Transdermal Specialties

Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level.

Scope of the Report:

This report studies the Next Generation Diabetes Therapy and Drug Delivery market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Next Generation Diabetes Therapy and Drug Delivery market by product type and applications/end industries.

The market growth is attributed to the rise in the number of diabetic patients globally and the increase in disposable income among these patients. The benefits of using these advanced devices over conventional products, such as painless mode of insulin delivery and improvement in adherence to medication, and rise in the healthcare expenditure are expected to increase the demand for these products, thus fueling the market growth. However, lack of awareness, cost restrains in the developing regions, and less variability in products are expected to hamper the growth.

Asia-Pacific possesses high market potential for the growth of next generation diabetes therapy and drug delivery market, owing to increase in demand for advanced diabetic products, high incidence of diabetes, and rise in healthcare expenditure. It has experienced fast-paced growth, in terms of production and development of advanced diabetic products.

The global Next Generation Diabetes Therapy and Drug Delivery market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Next Generation Diabetes Therapy and Drug Delivery.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Johnson & Johnson

Abbott Laboratories

Medtronic

Sanofi

Novo Nordisk

MannKind Corporation

Enteris BioPharma

Dexcom

Senseonics

Medtech

Synertech

Zosano Pharma

Relmada Therapeutics

Eli Lilly and Company

Transdermal Specialties

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Inhalable Insulin

Oral Insulin

Insulin Patches

CGM Systems

Artificial Pancreas

Market Segment by Applications, can be divided into

Diagnostic/Clinics

ICUs

Home Healthcare

READ MORE

Scope

Table of Contents

1 Next Generation Diabetes Therapy and Drug Delivery Market Overview

1.1 Product Overview and Scope of Next Generation Diabetes Therapy and Drug Delivery

1.2 Classification of Next Generation Diabetes Therapy and Drug Delivery by Types

1.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Comparison by Types (2017-2023)

1.2.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Types in 2017

1.2.3 Inhalable Insulin

1.2.4 Oral Insulin

1.2.5 Insulin Patches

1.2.6 CGM Systems

1.2.7 Artificial Pancreas

1.3 Global Next Generation Diabetes Therapy and Drug Delivery Market by Application

1.3.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Diagnostic/Clinics

1.3.3 ICUs

1.3.4 Home Healthcare

1.4 Global Next Generation Diabetes Therapy and Drug Delivery Market by Regions

1.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Next Generation Diabetes Therapy and Drug Delivery Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Next Generation Diabetes Therapy and Drug Delivery Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Next Generation Diabetes Therapy and Drug Delivery Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Next Generation Diabetes Therapy and Drug Delivery Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Next Generation Diabetes Therapy and Drug Delivery Status and Prospect (2013-2023)

1.5 Global Market Size of Next Generation Diabetes Therapy and Drug Delivery (2013-2023)

2 Manufacturers Profiles

2.1 Johnson & Johnson

2.1.1 Business Overview

2.1.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.2 Abbott Laboratories

2.2.1 Business Overview

2.2.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.3 Medtronic

2.3.1 Business Overview

2.3.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.4 Sanofi

2.4.1 Business Overview

2.4.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.5 Novo Nordisk

2.5.1 Business Overview

2.5.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.6 MannKind Corporation

2.6.1 Business Overview

2.6.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.7 Enteris BioPharma

2.7.1 Business Overview

2.7.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.8 Dexcom

2.8.1 Business Overview

2.8.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.9 Senseonics

2.9.1 Business Overview

2.9.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.10 Medtech

2.10.1 Business Overview

2.10.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.11 Synertech

2.11.1 Business Overview

2.11.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.12 Zosano Pharma

2.12.1 Business Overview

2.12.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.13 Relmada Therapeutics

2.13.1 Business Overview

2.13.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.14 Eli Lilly and Company

2.14.1 Business Overview

2.14.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.15 Transdermal Specialties

2.15.1 Business Overview

2.15.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

3 Global Next Generation Diabetes Therapy and Drug Delivery Market Competition, by Players

3.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Next Generation Diabetes Therapy and Drug Delivery Players Market Share

3.2.2 Top 10 Next Generation Diabetes Therapy and Drug Delivery Players Market Share

3.3 Market Competition Trend

4 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Regions

4.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue and Market Share by Regions

4.2 North America Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

4.3 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

4.5 South America Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

5 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries

5.1 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)

5.2 USA Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

5.3 Canada Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

5.4 Mexico Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

6 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries

6.1 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)

6.2 Germany Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

6.3 UK Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

6.4 France Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

6.5 Russia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

6.6 Italy Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries

7.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)

7.2 China Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

7.3 Japan Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

7.4 Korea Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

7.5 India Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

8 South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries

8.1 South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)

8.2 Brazil Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

8.3 Argentina Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

8.4 Colombia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Next Generation Diabetes Therapy and Drug Delivery by Countries

9.1 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)

9.2 Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

9.3 UAE Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

9.4 Egypt Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

9.5 Nigeria Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

9.6 South Africa Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

10 Global Next Generation Diabetes Therapy and Drug Delivery Market Segment by Type

10.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue and Market Share by Type (2013-2018)

10.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Type (2018-2023)

10.3 Inhalable Insulin Revenue Growth Rate (2013-2023)

10.4 Oral Insulin Revenue Growth Rate (2013-2023)

10.5 Insulin Patches Revenue Growth Rate (2013-2023)

10.6 CGM Systems Revenue Growth Rate (2013-2023)

10.7 Artificial Pancreas Revenue Growth Rate (2013-2023)

11 Global Next Generation Diabetes Therapy and Drug Delivery Market Segment by Application

11.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2013-2018)

11.2 Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Application (2018-2023)

11.3 Diagnostic/Clinics Revenue Growth (2013-2018)

11.4 ICUs Revenue Growth (2013-2018)

11.5 Home Healthcare Revenue Growth (2013-2018)

12 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast (2018-2023)

12.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast (2018-2023)

12.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Regions (2018-2023)

12.3 North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

12.4 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

12.6 South America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Next Generation Diabetes Therapy and Drug Delivery Picture

Table Product Specifications of Next Generation Diabetes Therapy and Drug Delivery

Table Global Next Generation Diabetes Therapy and Drug Delivery and Revenue (Million USD) Market Split by Product Type

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Types in 2017

Figure Inhalable Insulin Picture

Figure Oral Insulin Picture

Figure Insulin Patches Picture

Figure CGM Systems Picture

Figure Artificial Pancreas Picture

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) by Application (2013-2023)

Figure Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Applications in 2017

Figure Diagnostic/Clinics Picture

Figure ICUs Picture

Figure Home Healthcare Picture

Table Global Market Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2013-2023)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors

Table Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Medtronic Basic Information, Manufacturing Base and Competitors

Table Medtronic Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Novo Nordisk Basic Information, Manufacturing Base and Competitors

Table Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table MannKind Corporation Basic Information, Manufacturing Base and Competitors

Table MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Enteris BioPharma Basic Information, Manufacturing Base and Competitors

Table Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Dexcom Basic Information, Manufacturing Base and Competitors

Table Dexcom Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Senseonics Basic Information, Manufacturing Base and Competitors

Table Senseonics Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Medtech Basic Information, Manufacturing Base and Competitors

Table Medtech Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Synertech Basic Information, Manufacturing Base and Competitors

Table Synertech Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Zosano Pharma Basic Information, Manufacturing Base and Competitors

Table Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Relmada Therapeutics Basic Information, Manufacturing Base and Competitors

Table Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors

Table Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Transdermal Specialties Basic Information, Manufacturing Base and Competitors

Table Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Type and Applications

Table Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) by Players (2013-2018)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Players (2013-2018)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Players in 2016

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Players in 2017

Figure Global Top 5 Players Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share in 2017

Figure Global Top 10 Players Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share in 2017

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) by Regions (2013-2018)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Regions (2013-2018)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Regions (2013-2018)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Regions in 2017

Figure North America Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Europe Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure South America Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Table North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)

Table North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries (2013-2018)

Figure North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries (2013-2018)

Figure North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries in 2017

Figure USA Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Canada Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Mexico Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Table Europe Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) by Countries (2013-2018)

Figure Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries (2013-2018)

Figure Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries in 2017

Figure Germany Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure UK Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure France Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Russia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Italy Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries in 2017

Figure China Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Japan Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Korea Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure India Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Table South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)

Table South America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries (2013-2018)

Figure South America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries (2013-2018)

Figure South America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries in 2017

Figure Brazil Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Argentina Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Colombia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Countries in 2017

Figure Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure UAE Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Egypt Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure Nigeria Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Figure South Africa Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) by Type (2013-2018)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Type (2013-2018)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Type (2013-2018)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Type in 2017

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue Forecast by Type (2018-2023)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Share Forecast by Type (2018-2023)

Figure Global Inhalable Insulin Revenue Growth Rate (2013-2018)

Figure Global Oral Insulin Revenue Growth Rate (2013-2018)

Figure Global Insulin Patches Revenue Growth Rate (2013-2018)

Figure Global CGM Systems Revenue Growth Rate (2013-2018)

Figure Global Artificial Pancreas Revenue Growth Rate (2013-2018)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2013-2018)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Application (2013-2018)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Application (2013-2018)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Application in 2017

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue Forecast by Application (2018-2023)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Share Forecast by Application (2018-2023)

Figure Global Diagnostic/Clinics Revenue Growth Rate (2013-2018)

Figure Global ICUs Revenue Growth Rate (2013-2018)

Figure Global Home Healthcare Revenue Growth Rate (2013-2018)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

Figure Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

Figure South America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Johnson & Johnson

Abbott Laboratories

Medtronic

Sanofi

Novo Nordisk

MannKind Corporation

Enteris BioPharma

Dexcom

Senseonics

Medtech

Synertech

Zosano Pharma

Relmada Therapeutics

Eli Lilly and Company

Transdermal Specialties